carnosine has been researched along with Metabolic Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haus, JM; Thyfault, JP | 1 |
| Favero, G; Ferroni, M; Lonati, C; Moghadasian, MH; Rezzani, R | 1 |
| Aldini, G; Baye, E; de Courten, B; Hipkiss, A; Ukropcova, B; Ukropec, J | 1 |
1 review(s) available for carnosine and Metabolic Diseases
| Article | Year |
|---|---|
Physiological and therapeutic effects of carnosine on cardiometabolic risk and disease.
Topics: Animals; Cardiovascular Diseases; Carnosine; Chronic Disease; Clinical Trials as Topic; Dietary Supplements; Humans; Metabolic Diseases | 2016 |
2 other study(ies) available for carnosine and Metabolic Diseases
| Article | Year |
|---|---|
Therapeutic potential of carbonyl-scavenging carnosine derivative in metabolic disorders.
Topics: Aldehydes; Carnosine; Humans; Insulin Resistance; Metabolic Diseases; Obesity | 2018 |
A carnosine analog with therapeutic potentials in the treatment of disorders related to oxidative stress.
Topics: Abietanes; Animals; Anserine; Antioxidants; Apoptosis; Carnosine; Cell Line; Cell Survival; Inflammation; Metabolic Diseases; Microscopy, Electron, Scanning; Models, Biological; Muscle Fibers, Skeletal; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Sirtuins; Superoxide Dismutase | 2019 |